Boston Scientific To Acquire Silk Road Medical For $1.16B In Cash, Offering $44 Per Share; 30% Premium Over Last Closing Price; Deal To Enhance Neurovascular Portfolio And Close By Q4 2024 Pending Regulatory Approvals
Boston Scientific To Acquire Silk Road Medical For $1.16B In Cash, Offering $44 Per Share; 30% Premium Over Last Closing Price; Deal To Enhance Neurovascular Portfolio And Close By Q4 2024 Pending Regulatory Approvals
波士頓科學將以11.6億美元現金收購Silk Road Medical，每股報價爲44美元，較上次收盤價溢價30％。該交易預計於2024年第4季度在獲得監管批准後完成，以增強神經血管組合。
Boston Scientific To Acquire Silk Road Medical For $1.16B In Cash, Offering $44 Per Share; 30% Premium Over Last Closing Price; Deal To Enhance Neurovascular Portfolio And Close By Q4 2024 Pending Regulatory Approvals
波士頓科學將以11.6億美元現金收購Silk Road Medical，每股報價爲44美元，較上次收盤價溢價30％。該交易預計於2024年第4季度在獲得監管批准後完成，以增強神經血管組合。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。